Literature DB >> 16501090

Detection of cell-cell fusion mediated by Ebola virus glycoproteins.

Séverine Bär1, Ayato Takada, Yoshihiro Kawaoka, Marc Alizon.   

Abstract

Ebola viruses (EboV) are enveloped RNA viruses infecting cells by a pH-dependent process mediated by viral glycoproteins (GP) involving endocytosis of virions and their routing into acidic endosomes. As with well-characterized pH-dependent viral entry proteins, in particular influenza virus hemagglutinin, it is thought that EboV GP require activation by low pH in order to mediate fusion of the viral envelope with the membrane of endosomes. However, it has not yet been possible to confirm the direct role of EboV GP in membrane fusion and the requirement for low-pH activation. It was in particular not possible to induce formation of syncytia by exposing cells expressing EboV GP to acidic medium. Here, we have used an assay based on the induction of a beta-galactosidase (lacZ) reporter gene in target cells to detect cytoplasmic exchanges, indicating membrane fusion, with cells expressing EboV GP (Zaire species). Acidic activation of GP-expressing cells was required for efficient fusion with target cells. The direct role of EboV GP in this process is indicated by its inhibition by anti-GP antibodies and by the lack of activity of mutant GP normally expressed at the cell surface but defective for virus entry. Fusion was not observed when target cells underwent acidic treatment, for example, when they were placed in coculture with GP-expressing cells before the activation step. This unexpected feature, possibly related to the nature of the EboV receptor, could explain the impossibility of inducing formation of syncytia among GP-expressing cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16501090      PMCID: PMC1395460          DOI: 10.1128/JVI.80.6.2815-2822.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

Review 1.  Biosynthesis and role of filoviral glycoproteins.

Authors:  Heinz Feldmann; Viktor E Volchkov; Valentina A Volchkova; Ute Ströher; Hans-Dieter Klenk
Journal:  J Gen Virol       Date:  2001-12       Impact factor: 3.891

2.  Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence.

Authors:  Graham Simmons; Rouven J Wool-Lewis; Frédéric Baribaud; Robert C Netter; Paul Bates
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 3.  The structural biology of type I viral membrane fusion.

Authors:  Peter M Colman; Michael C Lawrence
Journal:  Nat Rev Mol Cell Biol       Date:  2003-04       Impact factor: 94.444

4.  Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection.

Authors:  Graham Simmons; Andrew J Rennekamp; Ning Chai; Luk H Vandenberghe; James L Riley; Paul Bates
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 5.  Membrane fusion mechanisms: the influenza hemagglutinin paradigm and its implications for intracellular fusion.

Authors:  T Stegmann
Journal:  Traffic       Date:  2000-08       Impact factor: 6.215

6.  Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses.

Authors:  S Y Chan; C J Empig; F J Welte; R F Speck; A Schmaljohn; J F Kreisberg; M A Goldsmith
Journal:  Cell       Date:  2001-07-13       Impact factor: 41.582

7.  Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection.

Authors:  Kartik Chandran; Nancy J Sullivan; Ute Felbor; Sean P Whelan; James M Cunningham
Journal:  Science       Date:  2005-04-14       Impact factor: 47.728

Review 8.  The pathogenesis of Ebola hemorrhagic fever.

Authors:  A Takada; Y Kawaoka
Journal:  Trends Microbiol       Date:  2001-10       Impact factor: 17.079

Review 9.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.

Authors:  J J Skehel; D C Wiley
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

10.  Antibody-dependent enhancement of Ebola virus infection.

Authors:  Ayato Takada; Heinz Feldmann; Thomas G Ksiazek; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more
  21 in total

Review 1.  Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme.

Authors:  Judith M White; Sue E Delos; Matthew Brecher; Kathryn Schornberg
Journal:  Crit Rev Biochem Mol Biol       Date:  2008 May-Jun       Impact factor: 8.250

2.  Discovery, synthesis, and biological evaluation of a novel group of selective inhibitors of filoviral entry.

Authors:  Maria V Yermolina; Jizhen Wang; Michael Caffrey; Lijun L Rong; Duncan J Wardrop
Journal:  J Med Chem       Date:  2011-01-04       Impact factor: 7.446

3.  Ebola virus entry requires the host-programmed recognition of an intracellular receptor.

Authors:  Emily Happy Miller; Gregor Obernosterer; Matthijs Raaben; Andrew S Herbert; Maika S Deffieu; Anuja Krishnan; Esther Ndungo; Rohini G Sandesara; Jan E Carette; Ana I Kuehne; Gordon Ruthel; Suzanne R Pfeffer; John M Dye; Sean P Whelan; Thijn R Brummelkamp; Kartik Chandran
Journal:  EMBO J       Date:  2012-03-06       Impact factor: 11.598

Review 4.  Filovirus entry.

Authors:  Graham Simmons
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

5.  Ebola virus-like particle-induced activation of NF-kappaB and Erk signaling in human dendritic cells requires the glycoprotein mucin domain.

Authors:  Osvaldo Martinez; Charalampos Valmas; Christopher F Basler
Journal:  Virology       Date:  2007-04-16       Impact factor: 3.616

6.  Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events.

Authors:  Melinda A Brindley; Laura Hughes; Autumn Ruiz; Paul B McCray; Anthony Sanchez; David A Sanders; Wendy Maury
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

7.  Ebola virus exploits a monocyte differentiation program to promote its entry.

Authors:  Osvaldo Martinez; Joshua C Johnson; Anna Honko; Benjamin Yen; Reed S Shabman; Lisa E Hensley; Gene G Olinger; Christopher F Basler
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

8.  A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner.

Authors:  Osvaldo Martinez; Esther Ndungo; Lee Tantral; Emily Happy Miller; Lawrence W Leung; Kartik Chandran; Christopher F Basler
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

9.  Enhancement of the influenza A hemagglutinin (HA)-mediated cell-cell fusion and virus entry by the viral neuraminidase (NA).

Authors:  Bin Su; Sébastien Wurtzer; Marie-Anne Rameix-Welti; Dominic Dwyer; Sylvie van der Werf; Nadia Naffakh; François Clavel; Béatrice Labrosse
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

Review 10.  Host cell factors in filovirus entry: novel players, new insights.

Authors:  Heike Hofmann-Winkler; Franziska Kaup; Stefan Pöhlmann
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.